Abstract
Familial risks for cancer are important for clinical counseling and understanding cancer etiology. The nationwide Swedish Family-Cancer Database includes all Swedes born in 1932 and later (0 to 68-year-old offspring) with their parents, totaling over 10.2 million individuals. Urological cancer cases were retrieved from the Swedish Cancer Registry up to year 2000. Standardized incidence ratios (SIR) and 95% confidence limits (CI) were calculated for age-specific familial risk in offspring by an exact proband status. The familial risks for offspring cancer were increased at all urological sites from concordant cancer in the parent and in a sibling proband. The highest SIRs by parent were for testicular and prostate cancer (4.26 and 2.45). When a sibling was affected, even kidney cancer (4.74) showed a high SIR. For kidney cancers, and also for prostate and testicular cancers, the SIRs were higher among siblings than among offspring and parents, which may indicate the involvement of recessive effects. Family members of patients with prostate cancer or von Hippel Lindau disease can expect organized clinical counseling, but family members of patients with other urological cancers are probably not counseled. Guidelines for clinical counseling or action level should be developed for all urological cancers because of the established familial risks. Urological cancers also offer a challenge to molecular geneticists attempting to identify the susceptibility genes underlying the familial clustering.
Similar content being viewed by others
References
Isaacs S, Kiemeney L, Baffo-Bonnie A, Beaty T, Walsh P (1995) Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst 87:991–996
Ponder B (1997) Genetic testing for cancer risk. Science 278:1050–1054
Smith RA, Cokkinides V, von Eschenbach AC, Levin B, Cohen C, Runowicz CD, et al (2002) American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 52:8–22
Petersen G, Codori A-M (2002) Genetic testing for familial cancer. In: Vogelstein B, Kinzler K (eds) The genetic basis of human cancer, 2nd edn. McGraw-Hill, New York pp 643–656
Burke W (2002) Genetic testing. New Engl J Med 347:1867–1875
Guttmacher AE, Collins FS (2002) Genomic medicine—a primer. N Engl J Med 347:1512–1520
Fernandez E, La Vecchia C, D’Avanzo B, Negri E, Franceschi S (1994) Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev 3:209–212
Aitken JF, Youl P, Green A, MacLennan R, Martin NG (1996) Accuracy of case-reported family history of melanoma in Queensland, Australia. Melanoma Res 6:313–317
Kerber R, Slattery M (1997) Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol 146:244–248
Gibbs M, Stanford J, McIndoe R, Jarvik G, Kolb S, Goode E, et al (1999) Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet 64:776–787
Glanz K, Grove J, Le Marchand L, Gotay C (1999) Underreporting of family history of colon cancer: correlates and implications. Cancer Epidemiol Biomarkers Prev 8:635–639
Eerola H, Blomqvist C, Pukkala E, Pyrhonen S, Nevanlinna H (2000) Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer 36:1143–1148
King T, Tong L, Pack R, Spencer C, Amos C (2002) Accuracy of family history of cancer as reported by men with prostate cancer. Urology 59:546–550
Carstensen B, Soll-Johanning H, Villadsen E, Söndergaard J, Lynge E (1996) Familial aggregation of colorectal cancer in the general population. Int J Cancer 68:428–435
Hemminki K, Jiang Y (2002) Familial and second gastric cancers: a nation wide epidemiologic study from Sweden. Cancer 94:1157–1165
Hemminki K, Jiang Y (2002) Familial and second esophageal cancers: a nation-wide epidemiologic study from Sweden. Int J Cancer 98:106–109
Hemminki K, Li X (2003) Familial and second primary pancreatic cancers: a nation-wide epidemiologic study from Sweden. Int J Cancer 103:525–530
Makinen T, Tammela TL, Hakama M, Stenman UH, Rannikko S, Aro J, Juusela H, Maattanen L, Auvinen A (2002) Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng/ml: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests. J Urol 166:1339–1342
Dong C, Lonnstedt I, Hemminki K (2001) Familial testicular cancer and second primary cancers in testicular cancer patients by histological type. Eur J Cancer 37:1878–1885
Czene K, Hemminki K (2002) Kidney cancer from the nation-wide Swedish Family-Cancer Database: familial risks and association with second primary malignancies. Kidney Internat 61:1806–1813
Czene K, Hemminki K (2003) Familiary papillary renal cell tumors and subsequent cancers: a nation-wide epidemiological study from Sweden. J Urol 169:1271–1275
Plna K, Hemminki K (2001) Familial bladder cancer in the national Swedish family cancer database. J Urol 166:2129–2133
Hemminki K, Czene K (2002) Age specific and attributable risks of familial prostate carcinoma from the Family-Cancer Database. Cancer 95:1346–1353
Hemminki K, Li X, Plna K, Granström C, Vaittinen P (2001) The nation-wide Swedish Family-Cancer Database: updated structure and familial rates. Acta Oncol 40:772–777
Hemminki K, Granström C (2002) Risk for familial breast cancer increases with age. Nature Genet 32:233
Hemminki K, Li X (2003) Familial risk of cancer by site and histopathology. Int J Cancer 103:105–109
Center for Epidemiology (2000) Cancer Incidence in Sweden 1998
Esteve J, Benhamou E, Raymond L (1994) Statistical methods in cancer research, vol. 128. IARC, Lyon
Hemminki K, Mutanen P (2001) Birth order, family size, and the risk of cancer in young and middle-aged adults. Br J Cancer 84:1466–1471
Hemminki K, Vaittinen P, Dong C, Easton D (2001) Sibling risks in cancer: clues to recessive or X-linked genes? Br J Cancer 84:388–391
Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600–1607
Hemminki K, Dong C, Vaittinen P (2001) Cancer risks to spouses and offspring in the Family-Cancer Database. Genet Epidemiol 20:247–257
Hemminki K, Jiang Y (2002) Cancer risks among long-standing spouses. Br J Cancer 86:1737–1740
IARC (2003) Tobacco Smoke and Involuntary Smoking, vol. 83. IARC, Lyon
Lichtenstein P, Holm N, Verkasalo P, Illiado A, Kaprio J, Koskenvuo M, et al (2000) Environmental and heritable factors in the causation of cancer. N Engl J Med 343:78–85
Hemminki K, Mutanen P (2001) Genetic epidemiology of multistage carcinogenesis. Mut Res 473:11–21
Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33–36
Heimdal K, Olsson H, Tretli S, Flodgren P, Borresen A, Fossa S (1996) Familial testicular cancer in Norway and southern Sweden. Br J Cancer 73:964–969
Westergaard T, Olsen J, Frisch M, Kroman N, Nielsen J, Melbye M (1996) Cancer risk in fathers and brothers of testicular cancer patients in Denmark. A population-based study. Int J Cancer 66:627–631
Rapley E, Crockford G, Teare D, Biggs P, Seal S, Barfoot R, Edwards S, Hamoudi R, Heimdal K, Fossa SD et al (2000) Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nature Genet 24:197–200
Hemminki K, Li X, Czene K (2003) Familial risk of cancer: data for clinical counseling and cancer genetics. Int J Cancer (in press)
Maddock I, Moran A, Maher E, Teare M, Norman A, Payne S, et al (1996) A genetic register for von Hippel-Lindau disease. J Med Genet 33:120–127
Maher E, Kaelin W (1997) Von Hippel-Lindau disease. Medicine 76:381–332
Friedrich C (1999) Von Hippel-Lindau syndrome. A pleomorphic condition. Cancer 86:2478–2482
Hemminki K, Li X, Collins V (2001) A population-based study of familial central nervous system hemangioblastomas. Neuroepidemiol 20:257–261
Walsh PC, Partin AW (1997) Family history facilitates the early diagnosis of prostate carcinoma. Cancer 80:1871–1874
de Koning HJ, Auvinen A, Berenguer Sanchez A, Calais Da Silva F, Ciatto S, Denis L, Gohagan JK, Hakama M, Hugosson J, Kranse R, Nelen V, Prorok PC, Schroder FH (2002) Large-scale randomized prostate cancer screening trials: program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial. Int J Cancer 97:237–244
Acknowledgements
The Family-Cancer Database was created by linking registers maintained at Statistics Sweden and the Swedish Cancer Registry.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hemminki, K., Li, X. & Czene, K. Familial risk of urological cancers: data for clinical counseling. World J Urol 21, 377–381 (2004). https://doi.org/10.1007/s00345-003-0375-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-003-0375-7